0000874015-15-000070.txt : 20150702
0000874015-15-000070.hdr.sgml : 20150702
20150702180510
ACCESSION NUMBER: 0000874015-15-000070
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150701
FILED AS OF DATE: 20150702
DATE AS OF CHANGE: 20150702
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000874015
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330336973
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
BUSINESS PHONE: 7609319200
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Monia Brett P
CENTRAL INDEX KEY: 0001537529
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19125
FILM NUMBER: 15971366
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
STREET 2: C/O ISIS PHARMACEUTICALS, INC.
CITY: CARLSBAD
STATE: CA
ZIP: 92010
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-07-01
0000874015
ISIS PHARMACEUTICALS INC
ISIS
0001537529
Monia Brett P
C/O ISIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT
CARLSBAD
CA
92010
0
1
0
0
SVP, Antisense Drug Discovery
Common Stock
2015-07-01
2015-07-01
5
J
0
127
48.586
A
4553
D
Common Stock
2015-07-02
2015-07-02
4
S
0
198
56.30
D
4355
D
Reporting 127 shares acquired under the Isis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on July 1, 2015. These 127 shares may not be sold until January 2, 2016.
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 7/1/2014.
/s/Brett Monia
2015-07-02